DAHANCA

DAHANCA (Danish Head and Neck Cancer Group) is a collaborative group of Danish doctors and researchers who specialize in the study and treatment of head and neck cancer. The group was established in 1976 with the aim of improving the prognosis and quality of life for patients with head and neck cancer through clinical trials and research.

History

The DAHANCA group was established in 1976. Since its inception, the group has conducted numerous clinical trials and research studies, contributing significantly to the understanding and treatment of head and neck cancer.

Research

DAHANCA's research focuses on various aspects of head and neck cancer, including its causes, diagnosis, treatment, and prevention. The group's research has led to several breakthroughs in the field, including the development of new treatment protocols and the identification of genetic factors that may contribute to the disease.

Clinical Trials

DAHANCA conducts clinical trials to test new treatments for head and neck cancer. These trials are essential for advancing medical knowledge and improving patient care. They often involve collaborations with other research institutions and pharmaceutical companies.

Collaborations

DAHANCA collaborates with various other research institutions and organizations, both nationally and internationally. These collaborations help to broaden the scope of the group's research and increase its impact.

See Also

• Head and Neck Cancer
• Clinical Trials
• Cancer Research

References

<references />

This article is a medical stub. You can help WikiMD by expanding it!
Most recent articles Ongoing trials	Wikipedia